AzTrials
AzTrials

Normative Oxygen Saturation Levels in InfantsBOSSNCT03092661

Baby Oxygen Saturation Study

An observational study of Normative Oxygen Saturation Levels in Infants, run by NHS Greater Glasgow and Clyde at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To define preliminary reference (normative) limits for healthy, newborn baby oxygen saturation parameters using the Masimo Radical 7® monitor. To assess protocol feasibility in terms of acceptability to parents and infants. Read more about this study

Who is it for?
Ages 1 hour to 1 month
How many people
40 participants
Where
1 siteUnited Kingdom
Study dates
27 Mar 2017to 28 Feb 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 hour to 1 month
  • All sexes
  • Child

Study population: The study will complete oximetry measurements from 40 newborn infants, recruited at the Princess Royal Maternity. Study participants will be newly born, healthy, appropriately grown, term infants delivered by elective caesarean section. These infants will generally be around 39 weeks' gestation. This group has been chosen due to their tightly grouped gestational and postnatal age ranges with the aim of reducing variability related to age or maturity. Pragmatically, mothers undergoing delivery by caesarean section are likely to remain in the hospital for 38-45 hours, thus participation in an oximetry study will not delay discharge.

Who may be able to join

  • Healthy term baby admitted to postnatal ward of Princess Royal Maternity.
  • Written informed parental consent.
  • Delivery by elective caesarean section.

Who cannot join

  • Significant congenital abnormality.
  • Any respiratory or cardiac concerns.
  • Treatment for suspected sepsis.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • Princess Royal maternity

    Glasgow, Scotland

    Helen Mactier, MD

    Recruiting

Other trials in United Kingdom

About this study

Official title: Reference Data for Neonatal Oxygen Saturation - a Pilot Study.

To define preliminary reference (normative) limits for healthy, newborn baby oxygen saturation parameters using the Masimo Radical 7® monitor.

To assess protocol feasibility in terms of acceptability to parents and infants.

To inform the design of a future larger study where reference limits will be fully defined across a wider gestational age group.

Read the detailed description

Blood oxygen saturation is the percentage of haemoglobin carrying oxygen. It is accepted that healthy term infants breathing room air have oxygen saturation levels of 95% or greater, similar to adults (Levesque 2000). Blood oxygen saturation levels have to be carefully balanced in infants who are born prematurely. High saturation levels are associated with retinopathy of prematurity (ROP) and lower saturation levels with increased mortality (SUPPORT 2010; BOOST II 2013).

Current practice is to maintain premature infants' oxygen saturations between 88 and 93%. After 36 weeks' postmenstrual age, the risk of ROP is greatly reduced and these target oxygen saturations are typically increased to greater than 93%. Lower saturations beyond this time are associated with poor weight gain and are considered to carry a risk of developing pulmonary hypertension (Poets 1998). Many of the smallest and most premature infants will continue to require supplemental inspired oxygen after 36 weeks' postmenstrual age in order to maintain saturations greater than 93%, so called "chronic lung disease of prematurity". Some of these infants will require to be discharged home on supplemental oxygen. The need for home oxygen is determined by measurement of pulse oximetry prior to discharge.

A recently developed device, the Masimo Radical 7, is now in widespread use in preterm infants nearing discharge from the neonatal unit. This device is more accurate (Bohnhorst 2002), derives extra physiological measures from the oxygen saturation data (heart rate and perfusion index) and offers longer-term data storage than other models currently in clinical use. In addition, the Masimo Radical 7 with its analysis software is capable of counting and measuring shorter-term dips in oxygen saturation (Sedowofia 2008). An oxygen saturation study can be measured in terms of the overall oxygen saturation, and/or the number, duration and severity of these dips. Increasing use of the Masimo Radical 7 to record oxygen saturation studies in preterm infants nearing discharge from the neonatal unit has, for a significant number of infants, revealed more than previously suspected episodes of reduced oxygen saturation which are frequently not clinically apparent. Because of a dearth of data recorded from healthy term babies in the immediate newborn period, the "normal" Masimo Radical 7 trace is not well defined and the significance of these short dips in oxygen saturation is not clear. Defining acceptable saturation limits depends on a complete understanding of what is normal: in other words, deriving adequate reference limits from hundreds of healthy neonates (CLSI 2008; Pan 1990).

Multiple studies of oxygen saturation levels in neonates have been conducted, but disparate devices and protocols, and heterogeneity in age, gestation and morbidity of subjects preclude any universal clinical decision limit for normal oxygen saturation profile in prematurely-born neonates. Furthermore, as noted above, most currently-used oxygen saturation monitors do not capture very short-term changes in oxygen saturation.

This study will define preliminary reference limits for pulse oximetry in newly born healthy term babies, in order better to be able to interpret oxygen saturation recordings made in preterm babies nearing term corrected age and hospital discharge. The investigators will assess feasibility of data collection, and use the data to inform a subsequent larger study.

Keywords
Oxygen saturation, Pulse oximetry, Neonate, Infant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen saturation graph

    A trend graph of saturation and heart rate for the recording.

    Measured: up to 24 hours

  2. Oxygen saturation summary statistics.

    Statistics describing the distribution of the saturation trend recorded.

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2017
  2. Study start27 Mar 2017
  3. Primary completion31 Jan 2018 (estimated)
  4. Study completion28 Feb 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03092661
Sponsor's protocol ID
GN16RM676P
Acronym
BOSS
Status last verified
Jul 2017
First submitted
22 Mar 2017
Last updated
11 Jul 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Normative Oxygen Saturation Levels in Infants, run by NHS Greater Glasgow and Clyde at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Helen Mactier, MD (+44 141 211 5249 ext. 25249, Helen.Mactier@ggc.scot.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen saturation graph (time frame: up to 24 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in